Literature DB >> 23083518

Dysregulation of toll-like receptor (TLR) 2 expression on monocytes and upregulation of the frequency of T cells expressing TLR2 in patients with chronic hepatitis C virus infection.

Andreas Ronit1, Mohammad Salem, Hans J Hartling, Julie C Gaardbo, Henrik Ullum, Jan Gerstoft, Susanne D Nielsen.   

Abstract

Toll-like receptors (TLRs) initiate inflammatory responses that may play a role in disease progression in patients infected with hepatitis C virus (HCV). TLR2 and TLR4 surface expression were assessed on CD14(+) monocytes, CD4(+) and CD8(+) T cells in treatment naïve patients with chronic HCV infection with fibrosis, without fibrosis, co-infected with human immunodeficiency virus (HIV), and in healthy controls. Increased expression of TLR2 was found on monocytes in HCV-infected patients with fibrosis (p < 0.01), co-infected with HIV (p = 0.03), and possibly in patients without fibrosis (p = 0.07) when compared to controls. TLR2 positive CD4(+) and CD8(+) T cells were upregulated in patients with fibrosis only (p < 0.01). However, expression of TLR2 was not associated with T cell activation. TLR4 expression was similar in patients and healthy controls. In conclusion, TLR2 expression on monocytes and the frequency of T cells expressing TLR2 may contribute to disease progression in chronic HCV infection.
© 2012 The Authors APMIS © 2012 APMIS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23083518     DOI: 10.1111/apm.12013

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  1 in total

1.  HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.

Authors:  Valli De Re; Mariangela De Zorzi; Laura Caggiari; Gianfranco Lauletta; Maria Lina Tornesello; Elisa Fognani; Marta Miorin; Vito Racanelli; Luca Quartuccio; Laura Gragnani; Sabino Russi; Fabio Pavone; Michela Ghersetti; Elena Garlatti Costa; Pietro Casarin; Riccardo Bomben; Cesare Mazzaro; Giancarlo Basaglia; Massimiliano Berretta; Emanuela Vaccher; Francesco Izzo; Franco Maria Buonaguro; Salvatore De Vita; Anna Linda Zignego; Paolo De Paoli; Riccardo Dolcetti
Journal:  Oncotarget       Date:  2016-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.